Development and validation of synthetic data generation over a federated learning computing framework to accelerate innovation and boost personalized medicine in hematological diseases
Gianluca Asti(IRCCS Humanitas Research Hospital), Matteo Della Porta(University of Milan), Rami S. Komrokji(Moffitt Cancer Center), Saverio D’Amico(Istituti di Ricovero e Cura a Carattere Scientifico), Silvia Uribe(Universidad Politécnica de Madrid), Victor Savevski(Humanitas University), Alessia Campagna(Humanitas University), Matteo Zampini(IRCCS Humanitas Research Hospital), Gastone Castellani(University of Bologna), Marilena Bicchieri(IRCCS Humanitas Research Hospital), Alejandro Almodóvar(Universidad Politécnica de Madrid), Patricia A. Apellániz(Universidad Politécnica de Madrid), Lars Bullinger(Stanford University), Federico Álvarez(Universidad Politécnica de Madrid), Juan Parras(Universidad Politécnica de Madrid), Imanol Isasa(University of the Basque Country), Ivan Ferrari(IRCCS Humanitas Research Hospital), António Almeida(Hospital da Luz), Andoni Beristain(Vicomtech), Rudolf Mayer(SBA Research), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Amer M. Zeidan(Yale Cancer Center), Borja Arroyo Galende(Universidad Politécnica de Madrid), Lin‐Pierre Zhao, Giulia Maggioni(Humanitas University), Luca Lanino(Humanitas University), Alessandro Buizza(Istituti di Ricovero e Cura a Carattere Scientifico), Elena Zazzetti(IRCCS Humanitas Research Hospital), Mattia Delleani(IRCCS Humanitas Research Hospital), Pierre Fenaux(Université Paris Cité), L. Cerdá Alberich(Instituto de Investigación Sanitaria La Fe), Francesco Casadei(Institute of Neurological Sciences), Alessandro Bruseghini(IRCCS Humanitas Research Hospital), Elisabetta Sauta(IRCCS Humanitas Research Hospital), Eleonora Iascone(IRCCS Humanitas Research Hospital), Santiago Zazo(Universidad Politécnica de Madrid)
Cited by 0
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia
|New England Journal of Medicine|2004|997
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450